1. Moran GJ, Rothman RE, Volturo GA.Emergency management of community-acquired bacterial pneumonia:what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines.Am J Emerg Med, 2013, 31:602-612.
[2]
2. Shimizu S, Gabazza EC, Ogawa T, et al.Role of thrombin in chronic rhinosinusitis-associated tissue remodeling.Am J Rhinol Allergy, 2011, 25:7-11.
[3]
3. Young E.The anti-inflammatory effects of heparin and related compounds.Thromb Res, 2008, 122:743-752.
[4]
4. Ogawa T, Shimizu S, Tojima I, et al.Heparin inhibits mucus hypersecretion in airway epithelial cells.Am J Rhinol Allergy, 2011, 25:69-74.
[5]
5. Bauer TT, Ewig S, Marre R, et al.CRB-65 predicts death from community-acquired pneumonia.J Intern Med, 2006, 260:93-101.
[6]
6. Xie X, Thorlacius H, Raud J, et al.Inhibitory effect of locally administered heparin on leukocyte rolling and chemoattractant induced firm adhesion in rat mesenteric venules in vivo.Br J Pharmacol, 1997, 122:906-910.
[7]
7. Lever R, Smailbegovic A, Page CP.Locally available heparin modulates inflammatory cell recruitment in a manner independent of anticoagulant activity.Eur J Pharmacol, 2010, 630:137-144.
[8]
8. Koenig A, Norgard-Sumnicht K, Linhardt R, et al.Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins.Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.J Clin Invest, 1998, 101:877-889.
[9]
9. Nelson RM, Cecconi O, Roberts WG, et al.Heparin oligosaccharides bind L-and P-selectin and inhibit acute inflammation.Blood, 1993, 82:3253-3258.
[10]
10. Mandell LA, Wunderink RG, Anzueto A, et al.Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.Clin Infect Dis, 2007, 44(Suppl 2):S27-S72.
[11]
11. Weis N, Almdal T.C-reactive protein--can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease? Eur J Intern Med, 2006, 17:88-91.
[12]
12. Lee JH, Kim J, Kim K, et al.Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.J Crit Care, 2011, 26:287-294.
[13]
13. Perera WR, Hurst JR, Wilkinson TMA, et al.Inflammatory changes, recovery and recurrence at COPD exacerbation.Eur Respir J, 2007, 29:527-534.
[14]
14. Stolz D, Christ-Crain M, Morgenthaler NG, et al.Copeptin, C-reactive protein, and procalcitonin as prognostric biomarkers in acute exacerbation of COPD.Chest, 2007, 131:1058-1067.
